Literature DB >> 1329255

Dipyridamole inhibits platelet aggregation induced by oxygen-derived free radicals.

J P De la Cruz1, P J García, F Sánchez de la Cuesta.   

Abstract

Pyrogallol (a generator of superoxide anions) caused 50% increase in platelet aggregation induced by 400 microM of arachidonic acid. Dipyridamole did not produce a statistically significant inhibition of arachidonic-acid induced platelet aggregation, but it caused 100% inhibition of pyrogallol-stimulated platelet aggregation. Ferrous salts (Fe2+) induced 34% platelet aggregation which was inhibited (79.6%) by a concentration of dipyridamole of 10 microM. Dipyridamole inhibited ferrous-induced lipid peroxidation with IC-50 values of 17.5 microM. When arachidonic acid was used as aggregating agent, the corresponding IC-50 value was 140.5 microM. These results indicate that dipyridamole prevented platelet activation induced by oxygen-derived free radicals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329255     DOI: 10.1016/0049-3848(92)90278-i

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

Review 1.  Anti-platelet therapy: phosphodiesterase inhibitors.

Authors:  Paolo Gresele; Stefania Momi; Emanuela Falcinelli
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

2.  The effect of reactive oxygen species on whole blood aggregation and the endothelial cell-platelet interaction in patients with coronary heart disease.

Authors:  Jonathan Watt; Marie-Ann Ewart; Fiona H Greig; Keith G Oldroyd; Roger M Wadsworth; Simon Kennedy
Journal:  Thromb Res       Date:  2012-04-19       Impact factor: 3.944

3.  Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients.

Authors:  Kholoud F Aliter; Rami A Al-Horani
Journal:  Curr Pharm Des       Date:  2021       Impact factor: 3.116

4.  Chronic Stress Facilitates the Development of Deep Venous Thrombosis.

Authors:  Tao Dong; Yu-Wen Cheng; Fei Yang; Pei-Wen Sun; Chen-Jie Zhu; Li Zhu; Guo-Xing Zhang
Journal:  Oxid Med Cell Longev       Date:  2015-10-20       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.